Terms ending in 2028
Bayer Pharma Aktiengesellschaft
Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,273,876 | Medicaments Containing Vardenafil Hydrochloride Trihydrate In force · High confidence | Bayer Intellectual Property GmbH | In force | High confidence | |
| US 8,153,616 | Combination Preparation for Oral Contraception and Oral Therapy of Dysfunctional Uterine Bleeding Containing Estradiol Valerate and Dienogest and Method of Using Same In force · Medium confidence | Bayer Intellectual Property GmbH | In force | Medium confidence | |
| US 8,124,782 | Process for the Preparation of 4-{4-[({[4-Chloro-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-Carboxamide In force · High confidence | Bayer Healthcare LLC | In force | High confidence | |
| US 9,051,316 | Substituted 4-ARYL-1,4-Dihydro-1,6-Naphthyridine Amides and Their Use In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 7,906,678 | Crystalline Potassium Salt of Lipoxin A4 Analogs In force · High confidence | The Brigham and Women's Hospital, Inc. | In force | High confidence | |
| US 9,737,488 | Pharmaceutical Composition for the Treatment of Cancer In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 8,227,511 | Substituted Chromanol Derivatives and Their Use In force · High confidence | Sunshine Lake Pharma Co., Ltd. | In force | High confidence | |
| US 8,557,776 | Compounds and Methods for 18F Labeled Agents In force · High confidence | Lantheus Biosciences Ltd. | In force | High confidence | |
| US 8,889,700 | 4-(4-Cyano-2-Thioaryl)DIHYDROPYRIMIDINONES and Their Use In force · High confidence | PH Pharma Co., Ltd. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.